Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
45 Leser
Artikel bewerten:
(0)

Interventional Cardiology and Peripheral Vascular Devices Market - Expected to Reach USD$ 31 Billion by 2021 - Research and Markets

DUBLIN, Dec 23, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Interventional Cardiology & Peripheral Vascular Devices Market by Type - Forecasts to 2021" report to their offering.

The interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 billion by 2021 from USD 21.83 billion in 2016, at a CAGR of 7.1%. On the basis of product, this market is broadly classified into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories.

On the basis of type, the angioplasty stents market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. The drug-eluting stents segment is projected to witness the highest growth in this market due to increasing number of regulatory approvals and new product launches.

On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the IVUS/OCT segment is projected to witness the highest growth in this market due to increasing penetration rates and rapid advancements & innovations in these systems.

On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is projected to witness the highest growth in this market due to the rising incidence of smoking and hypertension.

Geographically, the interventional cardiology and peripheral vascular devices market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily driven by the rising incidence of cardiovascular diseases, rapidly growing geriatric population, and technological advancements.

Companies Mentioned:

  • Abbott Laboratories
  • Accessclosure, Inc.
  • B. Braun Melsungen AG
  • Biosensors International Group Ltd.
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Cordis Corporation
  • Medtronic PLC
  • St. Jude Medical, Inc.
  • Terumo Corporation

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Angioplasty Market, By Procedure

7 Angioplasty Balloons Market, By Type

8 Angioplasty Stents Market, By Type

9 Catheters Market, By Type

10 Endovascular Aneurysm Repair (EVAR) Stent Grafts Market, By Type

11 Inferior Vena Cava (IVC) Filters Market, By Type

12 Plaque Modification Devices Market, By Type

13 Hemodynamic Flow Alteration Devices Market, By Type

14 Interventional Cardiology and Peripheral Vascular Device Accessories Market, By Type

15 Interventional Cardiology and Peripheral Vascular Devices Market, By Region

16 Competitive Landscape

17 Company Profile

For more information about this report visit http://www.researchandmarkets.com/research/ld22z3/interventional

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.